ABSTRACT
Hemolysis ................................................................................467 22.4.7 Effect of Ginsenoside Structure on Bioactivity ......................468 22.4.8 Potential Synergy, Multidrug-Resistant Cancer ......................469 22.4.9 In Vivo Animal Cancer Models ...............................................470 22.4.10 Human Anticancer Evidence ...................................................471
